Ingevity (NGVT) Misses Q1 EPS by 5c; Offers FY23 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Ingevity reports first quarter 2023 financial results
May 3, 2023 4:15 PM EDTHIGHLIGHTS: (comparisons versus prior year period)
Net sales of $392.6 million, up 2.6% Net income of $50.7 million and diluted earnings per share (EPS) of $1.35; adjusted earnings of $41.1 million and diluted adjusted EPS of $1.09 Adjusted EBITDA of $103.9 million and adjusted EBITDA margin of 26.5% Operating cash flow of $5.2 million with free cash flow of negative $20.2 million, reflecting seasonal inventory build Share repurchases of $33.4 million Converting Crossett, AR plant to run 100% on non-CTO feedstocks to produce oleo-based alternate fatty acids (AFA) Adjusted 2023 guidance for sales between $1.75 billion to $1.95 billion and adjusted EBITDA between... More